Exacerbation-related impairment of quality of life and work productivity in severe and very severe chronic obstructive pulmonary disease

International Journal of COPD

Volumn 8, Issue , 2013, Pages 641-652

  Solem, Caitlyn T ^a   Sun, Shawn X ^b   Sudharshan, Lavanya ^a   Macahilig, Cynthia ^c   Katyal, Monica ^c   Gao, Xin ^a  

^a PHARMERIT INTERNATIONAL   (United States)

^b FOREST RESEARCH INSTITUTE   (United States)

^c Medical Data Analytics   (United States)

Author keywords

Burden; Chronic obstructive pulmonary disease; Exacerbations; Health related quality of life; HRQoL; Utilities

Indexed keywords

AGED; ARTICLE; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; EMPLOYMENT STATUS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRODUCTIVITY; QUALITY OF LIFE; QUALITY OF WORKING LIFE; UNITED STATES;

BURDEN; CHRONIC OBSTRUCTIVE PULMONARY DISEASE; EXACERBATIONS; HEALTH-RELATED QUALITY OF LIFE; HRQOL; UTILITIES;

AGED; COST OF ILLNESS; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; EFFICIENCY; EMPLOYMENT; FEMALE; HUMANS; LUNG; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; QUESTIONNAIRES; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; UNITED STATES; WORK CAPACITY EVALUATION;

EID: 84890347333     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S51245     Document Type: Article

References (26)

1. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007; 370(9589): 765-773.
2. Vestbo J, Hurd SS, Agustí AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013; 187(4): 347-365.
3. Anzueto A, Leimer I, Kesten S. Impact of frequency of COPD exacerbations on pulmonary function, health status and clinical outcomes. Int J Chron Obstruct Pulmon Dis. 2009; 4: 245-251.
4. Gillissen A, Glaab T, Lewis M, Buhl R, Worth H. Statistical analysis of chronic obstructive pulmonary disease exacerbations in clinical studies: expectations and limitations. J Physiol Pharmacol. 2009; 60 Suppl 5: S7-S11.
5. Miravitlles M, Ferrer M, Pont A, et al; IMPAC Study Group. Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study. Thorax. 2004; 59(5): 387-395.
6. Toy EL, Gallagher KF, Stanley EL, Swensen AR, Duh MS. The economic impact of exacerbations of chronic obstructive pulmonary disease and exacerbation definition: a review. COPD. 2010; 7(3): 214-228.
7. Llor C, Molina J, Naberan K, Cots JM, Ros F, Miravitlles M; EVOCA study group. Exacerbations worsen the quality of life of chronic obstructive pulmonary disease patients in primary healthcare. Int J Clin Pract. 2008; 62(4): 585-592.
8. Rutten-van Mölken MP, Oostenbrink JB, Tashkin DP, Burkhart D, Monz BU. Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages? Chest. 2006; 130(4): 1117-1128.
9. Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998; 157(5 Pt 1): 1418-1422.
10. Ståhl E, Lindberg A, Jansson SA, et al. Health-related quality of life is related to COPD disease severity. Health Qual Life Outcomes. 2005; 3: 56.
11. Jones PW, Brusselle G, Dal Negro RW, et al. Patient-centred assessment of COPD in primary care: experience from a cross-sectional study of health-related quality of life in Europe. Prim Care Respir J. 2012; 21(3): 329-336.
12. Niewoehner DE. The impact of severe exacerbations on quality of life and the clinical course of chronic obstructive pulmonary disease. Am J Med. 2006; 119(10 Suppl 1): S38-S45.
13. Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. New Engl J Med. 2010; 363(12): 1128-1138.
14. Health Information Privacy [webpage on the Internet]. Washington, DC: US Department of Health & Human Services. Available from: http://www. hhs. gov/ocr/privacy/hipaa/understanding/index. html. Accessed October 10, 2013.
15. Rabe KF, Hurd S, Anzueto A, et al; Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007; 176(6): 532-555.
16. Celli BR, MacNee W; ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004; 23(6): 932-946.
17. Brooks R. EuroQol: the current state of play. Health Policy. 1996; 37(1): 53-72.
18. Pickard AS, Wilke C, Jung E, Patel S, Stavem K, Lee TA. Use of a preference-based measure of health (EQ-5D) in COPD and asthma. Respir Med. 2008; 102(4): 519-536.
19. Szende A, Leidy NK, Ståhl E, Svensson K. Estimating health utilities in patients with asthma and COPD: evidence on the performance of EQ-5D and SF-6D. Qual Life Res. 2009; 18(2): 267-272.
20. Meguro M, Barley EA, Spencer S, Jones PW. Development and validation of an improved, COPD-specific version of the St George Respiratory Questionnaire. Chest. 2007; 132(2): 456-463.
21. Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics. 1993; 4(5): 353-365.
22. Menn P, Weber N, Holle R. Health-related quality of life in patients with severe COPD hospitalized for exacerbations-comparing EQ-5D, SF-12 and SGRQ. Health Qual Life Outcomes. 2010; 8: 39.
23. Walters SJ, Brazier JE. Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Qual Life Res. 2005; 14(6): 1523-1532.
24. Jones PW. Interpreting thresholds for a clinically significant change in health status in asthma and COPD. Eur Respir J. 2002; 19(3): 398-404.
25. Jones PW. St George's Respiratory Questionnaire: MCID. COPD. 2005; 2(1): 75-79.
26. DiBonaventura Md, Paulose-Ram R, Su J, et al. The impact of COPD on quality of life, productivity loss, and resource use among the elderly United States workforce. COPD. 2012; 9(1): 46-57.